As Wall Street’s broader market averages continue to decline on Tuesday, following Monday’s significant sell-off, the idea of ...

Elevance Health, Inc. (ELV), with a market cap of $89.92 billion, is a leading health benefits company in the United States.

Elevance Health has struggled, with shares dropping 30% from its 52-week high and 21.3% over the past year. The managed care sector faces rising medical costs and reimbursement rate misalignments, ...

Special Needs Plans boosted a sluggish Medicare Advantage market during the annual enrollment period for 2025, a Modern ...

Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a ...

Analysts at Zacks Research lowered their Q1 2026 earnings estimates for shares of Elevance Health in a report released on Thursday, February 27th. Zacks Research analyst K. Dey now forecasts that the ...

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...

Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...

Intel heads the list, followed by Elevance Health and Accenture.